Fortum Inj. IV/ IM 2 gm

Country: Jordan

Language: English

Source: JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

Active ingredient:

Ceftazidime 2 gm

Available from:

مستودع أدوية سليمان طنوس وأولاده - Suleiman Tannous & Sons Co. Ltd

ATC code:

J01DD02

INN (International Name):

Ceftazidime 2 gm

Dosage:

2 gm

Units in package:

1Vial

Manufactured by:

Glaxo smithKline Manufacturing S.P.A Verona (ايطاليا)

Product summary:

9.28 :سعر الجمهور + الضريبة

Patient Information leaflet

FORTUM™
Ceftazidime
QUALITATIVE AND QUANTITATIVE COMPOSITION
_FORTUM_ injection contains 250 mg, 500 mg, 1 g, 2 g or 3 g of
ceftazidime (as pentahydrate).
_FORTUM_ _MONOVIAL_™ contains 1 g or 2 g of ceftazidime (as
pentahydrate).
PHARMACEUTICAL FORM
Powder for injection/infusion
CLINICAL PARTICULARS
INDICATIONS
Treatment of single or multiple infections caused by susceptible
organisms.
May be used alone as first choice drug before the results of
sensitivity tests are available.
May be used in combination with an aminoglycoside or most other
beta-lactam antibiotics.
May be used with an antibiotic against anaerobes when the presence of
Bacteroides fragilis is suspected.
Indications include:
-
severe infections e.g.
-
septicaemia, bacteraemia, peritonitis, meningitis.
-
infections in immunosuppressed patients
-
infections in patients in intensive care, e.g. infected burns
-
respiratory tract infections including lung infections in cystic
fibrosis
-
ear, nose and throat infections
-
urinary tract infections
-
skin and soft tissue infections
-
gastrointestinal, biliary and abdominal infections
-
bone and joint infections
-
infections associated with haemo- and peritoneal dialysis and with
continuous ambulatory peritoneal dialysis (CAPD)
-
prophylaxis: prostatic surgery (transurethral resection).
DOSAGE AND ADMINISTRATION
Dosage depends upon the severity, sensitivity, site and type of
infection and upon the age and renal function of the patient.
Use _FORTUM_ injection i.v. or by deep i.m. injection. Recommended
i.m. injection sites are the upper outer quadrant of the
gluteus maximus or lateral part of the thigh.
_FORTUM_ solutions may be given directly into the vein or introduced
into the tubing of a giving set if the patient is receiving
parenteral fluids.
_FORTUM_ _MONOVIAL _is for i.v. infusion only.
• Adults
1 to 6 g/day in two or three divided doses by i.v. or i.m. injection.
Urinary tract and less severe infections:
– 500 mg or 1 g every 12 h.
Most infections:
– 1 g every 8 h or 2 g every 12 h.
Very sev